Hepatoma Research

hr

Search

Systemic therapies for hepatocellular carcinoma: an evolving landscape

Filippo Pelizzaro, ... Fabio Farinati

Commentary|Published on: 8 May 2021
Guideline for stratified screening and surveillance in patients with high risk of primary liver cancer (2020)

Huiguo Ding, ... Specialist Committee of Cancer Prevention and Control of Chinese Preventive Medicine Association

Guideline|Published on: 25 Feb 2021

Submit a Manuscript

Announcement

The webinar "Minimally Invasive Surgery for HCC" chaired by Prof. Ho-Seong Han was held on July 21, 2021

Chair: Prof. Ho-Seong Han, the President of the Korean Society of Traumatology, Department of Surgery, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seoul, South Korea.

Time: July 21, 2021; 20:00 (South Korea, GMT+9)/20:00 (Tokyo, GMT+9)/13:00 (Italy, GMT+1)/19:00 (China, GMT+8)
Liver Tumors of Unidentified Primary: are all HCC or HCC-CCA?

Chair: Prof. Tania Roskams, Head of Department of Imaging and Pathology, Translational Cell and Tissue Research, Katholieke Universiteit Leuven and University Hospitals Leuven, Leuven, Belgium.

Time: September 21, 2021; 19:00 (China, GMT+8)/13:00 (Germany, GMT+1)

Accepted Manuscripts See more

Prognostic factors associated with survival in patients with hepatocellular carcinoma undergoing transarterial chemoembolization: An Australian multicenter cohort study

Gauri Mishra, Anouk Dev, Eldho Paul, William Kemp, Ammar Majeed, John Lubel, Sally Bell, Paul Gow, Amanda Nicoll, Siddharth Sood, Alex Thompson, Marno Ryan, Stuart K Roberts

Original Article |Published on: 30 Jul 2021
BOOST - A phase 3 trial of sorafenib versus best supportive care in first line treatment of hepatocellular carcinoma in patients with deteriorated liver function

Gennaro Daniele, Clorinda Schettino, Laura Arenare, Domenico Bilancia, Fabio Farinati, Piera Federico, Stefano Tamberi, Gino Crivellari, Sandro Barni, Raffaella Tortora, Francesco Izzo, Antonio Frassoldati, Luigi Cavanna, Claudia Mucciarini, Luigi Bolondi, Angelo Dinota, Filippo Pelizzaro, Maria Carmela Piccirillo, Piera Gargiulo, Massimo Di Maio, Ciro Gallo, Francesco Perrone, Bruno Daniele

Original Article |Published on: 29 Jul 2021

Other Types of Articles See more

Guideline for stratified screening and surveillance in patients with high risk of primary liver cancer (2020)

Huiguo Ding, ... Specialist Committee of Cancer Prevention and Control of Chinese Preventive Medicine Association

Guideline|Published on: 25 Feb 2021

The narrow ridge from liver damage to hepatocarcinogenesis

Jan Best, Guido Gerken

Editorial|Published on: 17 Apr 2021
From nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease: more than a single-letter change in an acronym

Giovanni Targher

Commentary|Published on: 11 Jun 2021
Systemic therapies for hepatocellular carcinoma: an evolving landscape

Filippo Pelizzaro, ... Fabio Farinati

Commentary|Published on: 8 May 2021
Systematic review of existing guidelines for NAFLD assessment

Filippo Monelli, ... Giulia Besutti

Systematic review|Published on: 7 Apr 2021

Review Articles See more

Steatohepatitic hepatocellular carcinoma

Michael S. Torbenson, Mathew M. Yeh

Systematic review|Published on: 11 May 2021
Epidemiology and aetiology of hepatocellular carcinoma in Sub-Saharan Africa

Daniel Mak, Anna Kramvis

video

Systematic review|Published on: 17 May 2021
GNMT: a multifaceted suppressor of hepatocarcinogenesis

Maria M. SImile, ... Francesco Feo

video

Systematic review|Published on: 8 May 2021
Immunotherapy and immunotherapy biomarkers for hepatocellular carcinoma

Samantha Armstrong, ... Aiwu Ruth He

Systematic review|Published on: 9 Mar 2021

Risk factors and management of post-liver transplant recurrence of hepatocellular carcinoma

Ashwin Rammohan, Mohamed Rela

Systematic review|Published on: 29 Jun 2021
Epidemiology and aetiology of hepatocellular carcinoma in Sub-Saharan Africa

Daniel Mak, Anna Kramvis

video

Systematic review|Published on: 17 May 2021
Hepatitis B-related hepatocellular carcinoma: surveillance strategy directed by immune-epidemiology

Chimaobi M. Anugwom, ... Jose D. Debes

Systematic review|Published on: 26 Mar 2021
Immune checkpoint inhibitors in liver transplant recipients - a review of current literature

Chao Yin, ... Coleman Smith

Systematic review|Published on: 8 Jun 2021

Original Articles See more

Steatosis/steatohepatitis: how sustainable is the non-invasive instrumental differential diagnosis in clinical practice?

Antonio Salvati, ... Maurizia Rossana Brunetto

Systematic review|Published on: 3 Feb 2021

Feasibility of totally laparoscopic hemi-hepatectomies for liver tumor, with consideration of correspondence for difficult cases

Yuichiro Otsuka, ... Hironori Kaneko

video

Systematic review|Published on: 7 Jan 2021
Defining the role of laparoscopic liver resection in elderly HCC patients - a propensity score matched analysis

Phoenix Wai Yan Wong, ... Chung Mau Lo

Systematic review|Published on: 24 May 2021
The impact of sarcopenia on the outcome of patients with cirrhosis with and without hepatocellular carcinoma who undergo liver transplantation

Francesca D’Arcangelo, ... Patrizia Burra

video

Systematic review|Published on: 7 Jan 2021
Robotic liver resection for hepatocellular carcinoma: a focus on anatomic resection

Yutaro Kato, ... Ichiro Uyama

Systematic review|Published on: 7 Jan 2021

Implications of diameter and volume-based measurement in assessment criteria for liver transplantation for hepatocellular carcinoma

Alice I. Graham, ... Stephen J. Wigmore

Systematic review|Published on: 7 Jan 2021

Validation of novel Japanese indication criteria and biomarkers among living donor liver transplantation recipients with hepatocellular carcinoma - a single center retrospective study

Akihiko Ichida, ... Kiyoshi Hasegawa

Systematic review|Published on: 21 Aug 2020
Distinctive magnetic resonance imaging findings of hepatocellular carcinoma after hepatitis C virus eradication with direct-acting antivirals

Takao Shimizu, ... Namiki Izumi

Systematic review|Published on: 26 Mar 2020

Most Cited Papers In Last Two Years See more

Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma

Sana Raza, ... Rohit A. Sinha

Review|Published on: 11 Dec 2019

Hypoalbuminemia: an underestimated, vital characteristic of hospitalized COVID-19 positive patients?

Giuliano Ramadori

Review|Published on: 3 Jun 2020
Circulating tumor DNAs and non-coding RNAs as potential biomarkers for hepatocellular carcinoma diagnosis, prognosis and response to therapy

Paola Guerriero, ... Elisa Callegari

video

Review|Published on: 19 Feb 2019

No evidence for higher rates of hepatocellular carcinoma after direct-acting antiviral treatment: a meta-analysis

Stephanie M. Rutledge, ... Raymond T. Chung

Meta-Analysis|Published on: 7 Aug 2019

Videos See more

Ongoing Special Issues See more

Special Issue Ebooks See more

About The Journal

ISSN

2454-2520 (Online) 2394-5079 (Print)

Publisher

OAE Publishing Inc.

Article Processing Charges

$900
Editor-in-Chief

Guang-Wen Cao

Executive Chief Editor

Giuliano Ramadori

Publishing Model

Gold Open Access

Copyright

Copyright is retained by author(s)
Publication Frequency

Continuously

Indexing

CAS

Journal Data Analysis

Total publications: 388

Total article views: 1,603,204

Total article downloads: 153,612

Open Archives

Portico

All published articles will be preserved here permanently:
https://www.portico.org/

Partners